The Neurologic Screening Exam
PART 17: Neurologic Disorders SECTION 1 DIAGNOSIS OF NEUROLOGIC DISORDERS 437 Approach to the Patient with Neurologic Disease Daniel H. Lowenstein, Joseph B. Martin, Stephen L. Hauser Neurologic diseases…
PART 17: Neurologic Disorders SECTION 1 DIAGNOSIS OF NEUROLOGIC DISORDERS 437 Approach to the Patient with Neurologic Disease Daniel H. Lowenstein, Joseph B. Martin, Stephen L. Hauser Neurologic diseases…
269e Atlas of Electrocardiography Ary L. Goldberger The electrocardiograms (ECGs) in this atlas supplement those illustrated in Chap. 268. The interpretations emphasize findings of specific teaching value. All of the…
PART 17: Neurologic Disorders SECTION 1 DIAGNOSIS OF NEUROLOGIC DISORDERS 437 Approach to the Patient with Neurologic Disease Daniel H. Lowenstein, Joseph B. Martin, Stephen L. Hauser Neurologic diseases…
PART 11: Disorders of the Respiratory System SECTION 1 DIAGNOSIS OF RESPIRATORY DISORDERS 305 Approach to the Patient with Disease of the Respiratory System Patricia A. Kritek, Augustine M….
PYROGENS The term pyrogen (Greek pyro, “fire”) is used to describe any substance that causes fever. Exogenous pyrogens are derived from outside the patient; most are microbial products, microbial toxins,…
PART 17: Neurologic Disorders SECTION 1 DIAGNOSIS OF NEUROLOGIC DISORDERS 437 Approach to the Patient with Neurologic Disease Daniel H. Lowenstein, Joseph B. Martin, Stephen L. Hauser Neurologic diseases…
PART 11: Disorders of the Respiratory System SECTION 1 DIAGNOSIS OF RESPIRATORY DISORDERS 305 Approach to the Patient with Disease of the Respiratory System Patricia A. Kritek, Augustine M….
PART 14: Disorders of the Gastrointestinal System SECTION 1 DISORDERS OF THE ALIMENTARY TRACT 344 Approach to the Patient with Gastrointestinal Disease William L. Hasler, Chung Owyang ANATOMIC CONSIDERATIONS…
Molecular Defects More than 90% of patients clinically classified as having MFS by the “Ghent criteria” have a mutation in the gene for fibrillin-1 (FBN1). Mutations in the same gene are…
Molecular Defects More than 90% of patients clinically classified as having MFS by the “Ghent criteria” have a mutation in the gene for fibrillin-1 (FBN1). Mutations in the same gene are…